Search
Now showing items 1-6 of 6
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)
Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients
with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ...
In vivo PPD reactivity and associated factors among HIV positive patients on HAART at the Makerere University Infectious Diseases Clinic.
(2009-08)
BACKGROUND:
It is estimated that a third of the world’s population is infected with tuberculosis (TB).
This epidemic is fueled by HIV, with reactivation rates of 8-10% / year and overall lifetime risk of 30% in HIV ...
Human immunodeficiency virus neurological complications: An overview of the Ugandan experience.
(Journal of NeuroVirology, 2005)
Sub-Saharan Africa, which has about 12% of the global population, is
home to almost 70% of individuals infected with human immunodeficiency
virus/acquired immunodeficiency syndrome (HIV/AIDS). A recent survey by
the ...
Dissertation barriers to timely initiation of antiretroviral therapy among HIV infected children admitted to mulago hospital paediatric wards.
(2007-08)
BACKGROUND:
The median survival of HIV infected children in the absence of treatment is 2 years, thus early initiation of ART is desirable.
In Uganda, ART is now being provided free of charge. However, some children still ...
Prevalence and factors associated with non-adherence to HAART among HIV-Positive women in reproductive age in Kayunga District
(2009-05)
Introduction: Globally approximately 40.3million people are infected with HIV, of which more 25.8million are in sub-Sahara Africa in 2007. Women living in sub-Saharan Africa are more affected by HIV/AIDS than any other ...
The effect of Aids defining conditions on immunological recovery among patients initiating antiretroviral therapy at JCRC, Kampala, Uganda
(2008-10)
BACKGROUND:
During 2005, the world health organization (WHO) estimated that there were over 1.3 million people receiving antiretroviral therapy (ART). As the number of individuals able to access treatment is ever increasing, ...